Drug intelligence / Profile preview

alpha-melanocyte stimulating hormone

Development stage
Phase 1
Modality
Peptides, Recombinant Proteins and Enzymes
01

Overview

Alpha-melanocyte stimulating hormone (α-MSH) is an endogenous tridecapeptide hormone and neuropeptide of the melanocortin family. It is produced primarily in the anterior pituitary gland but also in the skin and hypothalamus. Derived from pro-opiomelanocortin (POMC), α-MSH plays a central role in stimulating melanogenesis—the production of melanin by melanocytes—leading to pigmentation of skin, hair, and eyes. Beyond pigmentation, α-MSH regulates appetite and energy homeostasis via action on hypothalamic receptors; it also influences sexual behavior, exerts anti-inflammatory effects, modulates immune responses, and provides protection against ischemia-reperfusion injury. Its biological actions are mediated through non-selective full agonism at several melanocortin receptors (MC1R for pigmentation; MC3R/MC4R for appetite/metabolism). Synthetic analogues have been developed as drugs for photoprotection or other indications[7][4][5][6].

Other names
melanotropinα-MSHalpha MSH
02

Targets

MC4R (Melanocortin 4 receptor)MC3R (Melanocortin Receptor Type 3)MC1R (Melanocortin Type 1 Receptor)MC5R (Melanocortin 5 Receptor)

Beyond the preview

Go deeper on alpha-melanocyte stimulating hormone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-melanocyte stimulating hormone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call